Heterogeneous myocardial FDG uptake and the disease activity in cardiac sarcoidosis

JACC: Cardiovascular Imaging

Volumn 3, Issue 12, 2010, Pages 1219-1228

  Tahara, Nobuhiro ^a   Tahara, Atsuko ^a   Nitta, Yoshikazu ^a   Kodama, Norihiro ^a   Mizoguchi, Minori ^a   Kaida, Hayato ^a   Baba, Kenkichi ^a   Ishibashi, Masatoshi ^a   Hayabuchi, Naofumi ^a   Narula, Jagat ^b   Imaizumi, Tsutomu ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

cardiac sarcoidosis; dilated cardiomyopathy; emission tomography; F fluorodeoxyglucosepositron; heterogeneity

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FLUORODEOXYGLUCOSE F 18; GALLIUM CITRATE GA 67; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PREDNISOLONE; WARFARIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DIAGNOSTIC VALUE; DISEASE ACTIVITY; DRUG DOSE REDUCTION; DRUG TRANSPORT; ECHOCARDIOGRAPHY; FEMALE; HEART MUSCLE; HUMAN; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SARCOIDOSIS; SCINTIGRAPHY; SENSITIVITY AND SPECIFICITY;

ADRENAL CORTEX HORMONES; ADULT; AGED; AGED, 80 AND OVER; CARDIOMYOPATHIES; CARDIOMYOPATHY, DILATED; FASTING; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; JAPAN; MALE; MIDDLE AGED; MYOCARDIUM; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; SARCOIDOSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 78650256520     PISSN: 1936878X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcmg.2010.09.015     Document Type: Article

References (24)

1. J.M. Reich Mortality of intrathoracic sarcoidosis in referral vs population-based settings: influence of stage, ethnicity, and corticosteroid therapy Chest 121 2002 32 39
2. K. Iwai, T. Tachibana, T. Takemura, Y. Matsui, M. Kitaichi, and Y. Kawabata Pathological studies on sarcoidosis autopsy I. Epidemiological features of 320 cases in Japan Acta Pathol Jpn 43 1993 372 376
3. A. Uemura, S. Morimoto, S. Hiramitsu, Y. Kato, T. Ito, and H. Hishida Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies Am Heart J 138 1999 299 302
4. M. Sekiguchi, Y. Yazaki, M. Isobe, and M. Hiroe Cardiac sarcoidosis: diagnostic, prognostic, and therapeutic considerations Cardiovasc Drugs Ther 10 1996 495 510
5. A. Perry, and F. Vuitch Causes of death in patients with sarcoidosis A morphologic study of 38 autopsies with clinicopathologic correlations Arch Pathol Lab Med 119 1995 167 172
6. F. Terasaki, A. Ukimura, and B. Tsukada Enhanced expression of type 1 helper T-cell cytokines in the myocardium of active cardiac sarcoidosis Circ J 72 2008 1303 1307
7. W.C. Roberts, T.J. Vowels, J.M. Ko, J.E. Capehart, and S.A. Hall Cardiac transplantation for cardiac sarcoidosis with initial diagnosis by examination of the left ventricular apical "core" excised for insertion of a left ventricular assist device for severe chronic heart failure Am J Cardiol 103 2009 110 114
8. Central Japan Heart Study Group Y. Yazaki, M. Isobe, and M. Hiroe Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone Am J Cardiol 88 2001 1006 1010
9. C.Z. Chiu, S. Nakatani, and G. Zhang Prevention of left ventricular remodeling by long-term corticosteroid therapy in patients with cardiac sarcoidosis Am J Cardiol 95 2005 143 146
10. L.H. Brudin, S.O. Valind, and C.G. Rhodes Fluorine-18 deoxyglucose uptake in sarcoidosis measured with positron emission tomography Eur J Nucl Med 21 1994 297 305
11. C.J. Chen, B.F. Lee, and W.J. Yao Dual-phase 18F-FDG PET in the diagnosis of pulmonary nodules with an initial standard uptake value less than 2.5 AJR Am J Roentgenol 191 2008 475 479
12. H. Yamagishi, N. Shirai, and M. Takagi Identification of cardiac sarcoidosis with (13)N-NH(3)/(18)F-FDG PET J Nucl Med 44 2003 1030 1036
13. W. Okumura, T. Iwasaki, and T. Toyama Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis J Nucl Med 45 2004 1989 1998
14. S. Ishimaru, I. Tsujino, and T. Takei Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis Eur Heart J 26 2005 1538 1543
15. Diagnostic standard and guidelines for sarcoidosis Jpn J Sarcoidosis and Granulomatous Disorders [in Japanese] 27 2007 89 102
16. American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging M.D. Cerqueira, N.J. Weissman, and V. Dilsizian Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart Circulation 105 2002 539 542
17. E. Inglese, L. Leva, and R. Matheoud Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT J Nucl Med 48 2007 1662 1669
18. A.H. Khandani, C.R. Isasi, and M. Donald Blaufox Intra-individual variability of cardiac uptake on serial whole-body 18F-FDG PET Nucl Med Commun 26 2005 787 791
19. R.J. Gropler, B.A. Siegel, and K.J. Lee Nonuniformity in myocardial accumulation of fluorine-18-fluorodeoxyglucose in normal fasted humans J Nucl Med 31 1990 1749 1756
20. M.L. Bartlett, S.L. Bacharach, L.M. Voipio-Pulkki, and V. Dilsizian Artifactual inhomogeneities in myocardial PET and SPECT scans in normal subjects J Nucl Med 36 1995 188 195
21. T.R. Wallhaus, M. Taylor, and T.R. DeGrado Myocardial free fatty acid and glucose use after carvedilol treatment in patients with congestive heart failure Circulation 103 2001 2441 2446
22. N. Tokita, P. Zanzonico, and M. Dunphy Suppression of physiological myocardial fluorodeoxyglucose uptake J Am Coll Cardiol 43 Suppl A 2004 337A
23. Y.W. Wu, M. Naya, and T. Tsukamoto Heterogeneous reduction of myocardial oxidative metabolism in patients with ischemic and dilated cardiomyopathy using C-11 acetate PET Circ J 72 2008 786 792
24. O. Lindner, J. Vogt, and D. Baller Global and regional myocardial oxygen consumption and blood flow in severe cardiomyopathy with left bundle branch block Eur J Heart Fail 7 2005 225 230